Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
David Veesler
Affiliation
ORCID
Career Start Year
2008
Papers
161
H Index
61
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37503272
Hierarchical design of pseudosymmetric protein nanoparticles.
Res Sq
2023
37856551
Regulatory T cell-like response to SARS-CoV-2 in Jamaican fruit bats (Artibeus jamaicensis) transduced with human ACE2.
PLoS Pathog
2023
38014024
Full-spike deep mutational scanning helps predict the evolutionary success of SARS-CoV-2 clades.
2023
37905007
Local structural flexibility drives oligomorphism in computationally designed protein assemblies.
bioRxiv
2023
37645760
Structure and design of Langya virus glycoprotein antigens.
2023
38096058
Antigen spacing on protein nanoparticles influences antibody responses to vaccination.
2023
37989312
Broad receptor tropism and immunogenicity of a clade 3 sarbecovirus.
2023
38076876
Persistent immune imprinting after XBB.1.5 COVID vaccination in humans.
2023
36841235
Virus structures and molecular biology exchange glances.
2023
36711984
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants.
bioRxiv
2023
36824814
Regulatory T Cell-like Response to SARS-CoV-2 in Jamaican Fruit Bats ( <i>Artibeus jamaicensis</i> ) Transduced with Human ACE2.
bioRxiv
2023
36711543
Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2.
bioRxiv
2023
37398374
Hierarchical design of pseudosymmetric protein nanoparticles.
bioRxiv
2023
37075079
A replicon RNA vaccine can induce durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned.
PLoS Pathog
2023
37300832
Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail.
Cell Rep
2023
36859493
Automatic and accurate ligand structure determination guided by cryo-electron microscopy maps.
Nat Commun
2023
37292995
Antigen spacing on protein nanoparticles influences antibody responses to vaccination.
2023
37163615
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine.
Sci Transl Med
2023
35076256
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement.
Science
2022
35705092
Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge.
Cell Reports Medicine
2022
35762884
Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution.
Science
2022
35700730
Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein.
Cell
2022
35446645
Computational design of mechanically coupled axle-rotor protein assemblies.
Science
2022
36356052
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines.
Sci Immunol
2022
35383176
Structure-based design of stabilized recombinant influenza neuraminidase tetramers.
Nat Commun
2022
35879941
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial.
eClinicalMedicine
2022
36206752
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens.
Cell Reports Medicine
2022
35617431
Potent monoclonal antibody-mediated neutralization of a divergent Hendra virus variant.
Proceedings of the National Academy of Sciences of the United States of America
2022
35484405
Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants.
Nat Biotechnol
2022
36203553
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape.
bioRxiv
2022
35864232
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.
Nature
2022
35677069
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.
bioRxiv
2022
35988541
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice.
Cell Rep
2022
35412328
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice.
Sci Transl Med
2022
36264829
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.
Science
2022
35857703
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies.
Science
2022
35857529
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.
Science
2022
35606518
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice.
NPJ Vaccines
2022
36399443
Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains.
PLoS Pathogens
2022
35976993
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine.
Sci Transl Med
2022
34990214
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry.
Science
2022
35313570
Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines.
bioRxiv
2022
35239409
Architecture and antigenicity of the Nipah virus attachment glycoprotein.
Science
2022
35134084
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy.
PLoS Pathogens
2022
35016195
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
Nature
2022
35118471
Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail.
bioRxiv
2022
35114688
ACE2 binding is an ancestral and evolvable trait of sarbecoviruses.
Nature
2022
35123650
SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses.
Cell
2022
34931194
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
bioRxiv
2021
33809833
Functional Analysis of the Fusion and Attachment Glycoproteins of Mojiang Henipavirus.
Viruses
2021
1 - 50 of 161
Column Actions
Search
Recommended Authors
Collaborators
Alexandra C Walls
Co-authored papers
78
Neil P King
Co-authored papers
26
Lauren Carter
Co-authored papers
22
Christian Cambillau
Aix Marseille University and CNRS
Co-authored papers
18
Amalio Telenti
Vir Biotechnology Inc.
Co-authored papers
16
David Baker
University of Washington
Co-authored papers
16
Michael S Diamond
Washington University School of Medicine
Co-authored papers
13
Frank DiMaio
University of Washington
Co-authored papers
13
Nadine Czudnochowski
University of California san francisco
Co-authored papers
13
Mary Jane Navarro
Co-authored papers
12
Brooke Fiala
Co-authored papers
12
Michael Murphy
Co-authored papers
12
Wesley C Van Voorhis
Center for Emerging and Re-emerging Infectious Diseases, University of Washington
Co-authored papers
9
Bali Pulendran
Institute for Immunity, Stanford University School of Medicine, Stanford University
Co-authored papers
9
Prabhu S Arunachalam
Co-authored papers
9
John C Kraft
Co-authored papers
8
Julia Noack
University of California san francisco
Co-authored papers
7
Rita E Chen
Co-authored papers
7
Laura A VanBlargan
Washington University School of Medicine
Co-authored papers
7
Francois Villinger
Co-authored papers
7
Derek T O'Hagan
Co-authored papers
7
Harry Kleanthous
Co-authored papers
7
Mehul S Suthar
Co-authored papers
6
Robbert G van der Most
Co-authored papers
6
Bridget Carragher
Columbia University
Co-authored papers
5
Jason S McLellan
Co-authored papers
5
Ralph S Baric
University of North Carolina
Co-authored papers
5
Nisar Farhat
University of California los angeles
Co-authored papers
5
Kelly K Lee
University of Washington
Co-authored papers
5
Melody G Campbell
Fred Hutchinson Cancer Center
Co-authored papers
5
1 - 30